Fortis Group Advisors’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-307,987
Closed -$6.42M 530
2025
Q1
$6.42M Buy
307,987
+276,707
+885% +$5.25M 1.25% 20
2024
Q4
$578K Sell
31,280
-12,472
-29% -$240K 0.11% 121
2024
Q3
$858K Sell
43,752
-3,346
-7% -$66.6K 0.16% 101
2024
Q2
$924K Sell
47,098
-326,931
-87% -$6.2M 0.18% 83
2024
Q1
$6.74M Sell
374,029
-8,955
-2% -$162K 1.24% 24
2023
Q4
$7.81M Hold
382,984
1.93% 10
2023
Q3
$7.81M Buy
382,984
+112,326
+42% +$2.13M 2.39% 9
2023
Q2
$5.08M Sell
270,658
-181,672
-40% -$3.66M 1.35% 22
2023
Q1
$9.48M Buy
+452,330
New +$9.1M 2.86% 8

Other funds holding BTAL

Fortis Group Advisors's BTAL Position: Q2 2025 in Review

Fortis Group Advisors sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q2 2025, closing a stake of 307,987 shares — an estimated $6.42M sold.

Fortis Group Advisors first reported a position in BTAL in Q1 2023 and held it in 9 quarters. The position peaked at $9.48M in Q1 2023. 80 funds tracked by Wall St. Rank hold BTAL as of Q2 2025.

  • Fortis Group Advisors reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q2 2025 after selling out during the quarter.
  • Fortis Group Advisors sold 307,987 AGF US Market Neutral Anti-Beta Fund shares in Q2 2025, an estimated $6.42M.
  • Fortis Group Advisors first reported a position in AGF US Market Neutral Anti-Beta Fund in Q1 2023 and held it in 9 quarters.
  • Fortis Group Advisors's AGF US Market Neutral Anti-Beta Fund position peaked at $9.48M in Q1 2023.
  • 80 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2025.

Based on Fortis Group Advisors's 13F filing for Q2 2025, filed 8 Aug 2025.